SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 132 filers reported holding SERES THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $326,955 | -60.0% | 137,376 | -19.6% | 0.00% | -100.0% |
Q2 2023 | $818,046 | +17.5% | 170,782 | +39.1% | 0.00% | 0.0% |
Q1 2023 | $696,220 | +1.3% | 122,790 | +0.0% | 0.00% | 0.0% |
Q4 2022 | $687,473 | -8.2% | 122,763 | +5.3% | 0.00% | 0.0% |
Q3 2022 | $749,000 | +142.4% | 116,619 | +29.1% | 0.00% | – |
Q2 2022 | $309,000 | -50.0% | 90,359 | +4.1% | 0.00% | -100.0% |
Q1 2022 | $618,000 | -10.7% | 86,827 | +4.5% | 0.00% | – |
Q4 2021 | $692,000 | +114.2% | 83,053 | +78.8% | 0.00% | – |
Q3 2021 | $323,000 | -68.3% | 46,454 | +8.5% | 0.00% | -100.0% |
Q2 2021 | $1,020,000 | +3.3% | 42,810 | -10.7% | 0.00% | 0.0% |
Q1 2021 | $987,000 | -65.4% | 47,913 | -58.9% | 0.00% | 0.0% |
Q4 2020 | $2,854,000 | +2670.9% | 116,518 | +727.6% | 0.00% | – |
Q1 2018 | $103,000 | -2.8% | 14,079 | +34.3% | 0.00% | – |
Q4 2017 | $106,000 | -68.3% | 10,483 | -49.8% | 0.00% | – |
Q3 2017 | $334,000 | +163.0% | 20,867 | +85.4% | 0.00% | – |
Q2 2017 | $127,000 | -54.5% | 11,253 | -59.9% | 0.00% | – |
Q4 2016 | $279,000 | -12.0% | 28,096 | +9.2% | 0.00% | – |
Q3 2016 | $317,000 | -31.8% | 25,731 | +60.8% | 0.00% | -100.0% |
Q2 2016 | $465,000 | +83.1% | 16,001 | +66.7% | 0.00% | – |
Q1 2016 | $254,000 | -16.2% | 9,596 | +11.1% | 0.00% | – |
Q4 2015 | $303,000 | -65.0% | 8,639 | -70.4% | 0.00% | -100.0% |
Q3 2015 | $865,000 | – | 29,178 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
Knott David M Jr | 470,000 | $2,251 | 0.90% |
GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |